Target intelligence / Profile preview

DBF4-dependent kinase regulatory subunit (DBF4)

Target
DBF4
Molecular classification
Enzyme, Protein kinase regulatory subunit, Cell cycle regulator
01

Overview

DBF4 is the regulatory subunit of the Cdc7-Dbf4 kinase (DDK) complex, essential for the initiation of DNA replication during the S phase of the cell cycle. DBF4 protein levels oscillate during the cell cycle, peaking at the G1/S transition and remaining high through S and G2/M phases, thereby controlling Cdc7 kinase activity. The DBF4/Cdc7 complex phosphorylates the minichromosome maintenance (MCM) protein complex, activating it for DNA unwinding and replication fork assembly[1][2][3][4]. DBF4 is considered a promising therapeutic target in cancer due to its role in promoting cell cycle progression and DNA synthesis, and its overexpression is linked to neoplastic transformation in some tumor types[3]. Drugs that inhibit this kinase complex prevent the initiation of DNA replication, leading to cell cycle arrest and potential selective toxicity in rapidly proliferating cells[3][4].

Other names
Protein DBF4 homolog AASKDBF4AZDBF1Chiffon homolog AActivator of S phase kinaseCHIFDBF4-type zinc finger-containing protein 1
02

Mechanism of action

Inhibition of Cdc7-Dbf4 kinase activity, blockade of DNA replication initiation, cell cycle arrest

03

Biological functions

Initiation of DNA replicationCell cycle progressionReplisome assemblyRegulation of DNA synthesis
04

Disease associations

CancerNeoplastic transformationGenomic instability
05

Safety considerations

Potential for off-target cell cycle arrest in non-tumor cellsrisk of hematopoietic toxicitygenomic instability upon inhibition[3][4]
06

Interacting drugs

Inhibitors targeting DDK (Cdc7-Dbf4 complex) such as XL413 and PHA-767491 (directly target CDC7, but functionally block DBF4-dependent activity)[4]
07

Biomarkers

Overexpression in some tumorselevated DDK activity in cancerscell cycle-associated oscillations of DBF4 protein levels[3][4]

Beyond the preview

Go deeper on DBF4-dependent kinase regulatory subunit (DBF4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DBF4-dependent kinase regulatory subunit (DBF4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call